CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Clinical trials for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME trials appear
Sign up with your email to follow new studies for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Childhood cancer immunotherapy trial pulled before starting
Disease control TerminatedThis study was designed to test two immunotherapy drugs, nivolumab and ipilimumab, in children and young adults with cancers that returned or didn't respond to treatment and have many genetic mutations. The goal was to see if the combination could shrink tumors or help patients l…
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope for kids with aggressive brain cancers: early trial tests Immune-Boosting drug
Disease control OngoingThis early-stage trial is testing the safety and early effectiveness of a drug called pembrolizumab in children and young adults whose aggressive brain tumors have come back or stopped responding to standard treatments. The drug is a type of immunotherapy designed to help the bod…
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 13, 2026 20:17 UTC